upcomingGrant
MRC small molecule high throughput screen using AstraZeneca facilities
Executive Summary
This Medical Research Council (MRC) opportunity provides up to £270,000 to enable researchers to conduct high-throughput small molecule screening utilising AstraZeneca's proprietary compound library and robotic screening infrastructure.
Expected Launch
January 2027
Funding Body
Innovate UK
Eligible Applicants
Academic, SME, Large, Charity, RTO
Funding Available & Project Rates
Total fund of £1 million with a maximum award of £270,000
Official PortalView Competition Brief
Target Sectors
healthcarebiotechnology
Technology Scope
small moleculehigh throughput screeningcompound librarydrug discoveryscreening robots
Ready to Apply?
Draft This Application with ZenGrants
Accelerate your application prep with ZenGrants AI discovery, sector research, and assessor-aligned proposal drafting for MRC small molecule high throughput screen using AstraZeneca facilities.
Competition Scope & Overview
Apply for funding to run a high throughput screen using AstraZeneca’s compound library and screening robots. Lead: MRC